COMMUNIQUÉS West-GlobeNewswire

Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025
29/05/2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery [...]
NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025
29/05/2025
LNCB74 is in a Phase 1, open-label, first-in-human study that will include dose escalation, safety, and biomarker backfills and randomized dose expansion/optimization The study is currently enrolling in dose escalation [...]
Amneal to Participate at Upcoming Investor Conferences in June
29/05/2025
BRIDGEWATER, N.J., May 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) will participate in two upcoming investor conferences: Jefferies Global Healthcare Conference on June 5, 2025, with company [...]
Annexon Biosciences to Present at the Jefferies Global Healthcare Conference
29/05/2025
BRISBANE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical [...]
Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences
29/05/2025
FOSTER CITY, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
29/05/2025
SAN FRANCISCO, May 29, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, [...]
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) For Extended-Release Oral Suspension at SLEEP 2025
29/05/2025
– 14 abstracts accepted, including four oral presentations – – Interim analysis of real-world REFRESH study demonstrated clinically significant efficacy and improvement of EDS for patients who switched from twice- [...]
Gyre Therapeutics Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
29/05/2025
SAN DIEGO, May 29, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems [...]
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
29/05/2025
LONDON, May 29, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will present at the following investor conferences in June: Jefferies 2025 Global [...]
Cytokinetics to Participate in the Jefferies Global Healthcare Conference
29/05/2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company’s management team are scheduled to participate in a fireside chat at [...]
Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
29/05/2025
WESTLAKE VILLAGE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
Theratechnologies Reports on its Annual Meeting of Shareholders
29/05/2025
MONTREAL, May 29, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, reported the voting results from its [...]
Theratechnologies rend compte de son assemblée annuelle des actionnaires
29/05/2025
MONTRÉAL, 29 mai 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade commercial, a rapporté les résultats du vote [...]
NeuroOne to Attend MedInvest’s MedTech, AI & Digital Health Conference on June 3-4, 2025
29/05/2025
EDEN PRAIRIE, Minn., May 29, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]
VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform
29/05/2025
VERAXA Attending ASCO and BIO with Cantor Fitzgerald, Voyager's Recently Retained Capital Markets Advisor, and Hosting Meetings with Potential Partners and Investors ZURICH, SWITZERLAND, May 29, 2025 -- VERAXA Biotech [...]
Basel Medical Group Ltd Reaffirms Strong Financial Position Amid Market Volatility
29/05/2025
Singapore, May 29, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”) , today reaffirmed the strength of its underlying financial performance and strategic outlook, despite recent [...]
Together we Walk at Breakthrough T1D Walk
29/05/2025
Throughout June close to 50 communities will be gathering across Canada to raise funds for type 1 diabetes research TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- Breakthrough T1D™ Walk (formerly JDRF Walk to Cure Diabetes) [...]
Ensemble, On Marche à la Marche Percée DT1
29/05/2025
Tout au long du mois de juin, près de 50 communautés se réuniront dans tout le Canada pour amasser des fonds en faveur de la recherche sur le diabète de type 1 TORONTO, 29 mai 2025 (GLOBE NEWSWIRE) -- La Marche Percée [...]
Sienna Senior Living Inc. Announces Results From Annual and Special Meeting
29/05/2025
MARKHAM, Ontario, May 29, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) is pleased to announce that it has received shareholder approval in respect of all resolutions to [...]

Pages